CLL Society is proud to be a member of the CLL Advocates Network (CLLAN). This global network of CLL patient advocate organizations, in partnership with AstraZeneca, released the White Paper, Compromised: Uncovering the immune-related challenges facing people with chronic lymphocytic leukaemia.
CLL Society remains committed to advocating for the needs of those who are considered immunocompromised. This includes all of those diagnosed with CLL or SLL, regardless of their treatment status.
